Harri Alenius Selected Research

Harri Alenius Research Topics

Disease

45	Inflammation (Inflammations) 06/2022 - 01/2002
22	Asthma (Bronchial Asthma) 01/2022 - 04/2004
15	Hypersensitivity (Allergy) 01/2022 - 01/2002
14	Atopic Dermatitis (Atopic Eczema) 10/2019 - 11/2004
10	Contact Dermatitis (Eczema, Contact) 01/2021 - 04/2003
9	Pneumonia (Pneumonitis) 01/2021 - 11/2005
6	Dermatitis 02/2014 - 04/2003
6	Latex Hypersensitivity (Latex Allergy) 05/2011 - 10/2002
4	Rhinitis 01/2021 - 08/2013
4	Pulmonary Eosinophilia (Eosinophilic Pneumonia) 09/2015 - 01/2009
4	Skin Diseases (Skin Disease) 01/2008 - 01/2005
3	Psoriasis (Pustulosis Palmaris et Plantaris) 10/2021 - 04/2005
3	Necrosis 01/2021 - 10/2015
3	Allergic Contact Dermatitis 01/2021 - 10/2007
3	Allergic Rhinitis 11/2017 - 01/2014
3	Fibrosis (Cirrhosis) 01/2017 - 10/2014
2	Eczema 01/2021 - 10/2004
2	Low Back Pain (Lumbago) 01/2021 - 12/2019
2	Egg Hypersensitivity (Egg Allergy) 01/2021 - 01/2021
2	Neoplasms (Cancer) 12/2019 - 01/2017
2	Granuloma 01/2017 - 10/2014
2	Acne Vulgaris 01/2016 - 01/2014
2	Sleep Deprivation 01/2016 - 01/2013
2	Airway Remodeling 01/2015 - 01/2011
2	Eosinophilia 10/2014 - 10/2003
2	Virus Diseases (Viral Diseases) 05/2012 - 04/2010
2	Infections 04/2010 - 02/2008
2	Anaphylaxis (Anaphylactic Shock) 10/2004 - 06/2003

Drug/Important Bio-Agent (IBA)

23	AllergensIBA 01/2019 - 01/2002
20	CytokinesIBA 10/2021 - 03/2002
15	Immunoglobulin E (IgE)IBA 01/2021 - 01/2002
11	Proteins (Proteins, Gene)FDA Link 11/2017 - 10/2002
8	Biomarkers (Surrogate Marker)IBA 10/2021 - 01/2016
7	ChemokinesIBA 07/2013 - 11/2004
6	Messenger RNA (mRNA)IBA 01/2021 - 05/2006
6	AntibodiesIBA 08/2014 - 04/2003
6	LatexIBA 05/2011 - 05/2002
5	MicroRNAs (MicroRNA)IBA 01/2021 - 07/2007
5	LigandsIBA 01/2017 - 11/2004
5	SuperantigensIBA 08/2014 - 11/2004
5	OvalbuminIBA 12/2006 - 01/2002
4	AntigensIBA 12/2019 - 03/2002
4	Carbon Nanotubes (Carbon Nanotube)IBA 01/2017 - 10/2014
4	titanium dioxide (Titania)FDA Link 03/2015 - 02/2010
4	Rubber (Elastica)IBA 05/2011 - 05/2002
3	Biological ProductsIBA 12/2021 - 01/2013
3	InterleukinsIBA 01/2021 - 10/2015
3	Irritants (Vesicants)IBA 12/2020 - 06/2007
3	AsbestosIBA 01/2017 - 10/2014
3	Interleukin-6 (Interleukin 6)IBA 04/2016 - 01/2009
3	NeuropeptidesIBA 01/2013 - 09/2010
3	HaptensIBA 01/2012 - 06/2007
3	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 09/2010 - 04/2004
2	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2021 - 01/2005
2	Silicon Dioxide (Silica)FDA LinkGeneric 01/2021 - 03/2015
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 01/2015
2	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 01/2018
2	CelluloseIBA 02/2019 - 01/2018
2	C-Reactive ProteinIBA 04/2016 - 10/2015
2	Interleukin-13IBA 01/2016 - 09/2015
2	Antiviral Agents (Antivirals)IBA 12/2014 - 04/2010
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 06/2014 - 01/2014
2	Interleukin-17 (Interleukin 17)IBA 01/2014 - 01/2009
2	Interleukin-33IBA 11/2013 - 05/2012
2	Chemokine ReceptorsIBA 07/2013 - 01/2010
2	OxazoloneIBA 01/2012 - 12/2010
2	Protein Isoforms (Isoforms)IBA 06/2011 - 04/2004
2	staphylococcal enterotoxin BIBA 12/2005 - 11/2004
2	CC ChemokinesIBA 04/2005 - 11/2004
1	Filaggrin ProteinsIBA 06/2022
1	Long Noncoding RNAIBA 01/2022
1	Calcineurin InhibitorsIBA 12/2021
1	IsocyanatesIBA 10/2021
1	Egg ProteinsIBA 01/2021
1	NickelIBA 01/2021
1	PowdersIBA 01/2021
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2021
1	Chemokine CCL26IBA 01/2021
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021
1	Cell Adhesion MoleculesIBA 01/2021
1	Interleukin-8 (Interleukin 8)IBA 01/2021
1	collagen type I trimeric cross-linked peptideIBA 01/2021
1	Monocyte Chemoattractant ProteinsIBA 01/2021
1	Chemokine CCL5IBA 01/2021
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 01/2021
1	Macrophage Inflammatory Proteins (Macrophage Inflammatory Protein 1)IBA 01/2021
1	Collagen Type I (Type I Collagen)IBA 01/2021
1	Vascular Endothelial Growth Factor CIBA 01/2021
1	Vascular Endothelial Growth Factor DIBA 01/2021
1	TIE-2 Receptor (Receptor, TIE 2)IBA 01/2021
1	Chemokine CCL11IBA 01/2021
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2020
1	NanovaccinesIBA 12/2019
1	Cancer VaccinesIBA 12/2019
1	Neoplasm Antigens (Tumor Antigens)IBA 12/2019

Therapy/Procedure

5	Immunotherapy 12/2021 - 02/2004
3	Therapeutics 10/2019 - 01/2008
1	Tertiary Prevention 12/2021
1	Role Playing (Playing, Role) 01/2020
1	Intravenous Infusions 12/2019